Fund Holdings

Crestline Management, LP

Filing Period:
Securities
SharesValue ($K)
Q4 2025
Q1 2026
Change
Q4 2025
Q1 2026
Weight (%)
Change
8X8 INC NEW0990,850+990,85001,644,8113.56%+1,644,811
SANA BIOTECHNOLOGY INC0755,736+755,73602,176,5204.70%+2,176,520
DENALI THERAPEUTICS INC(DNLI)02,210,732+2,210,732042,446,05491.74%+42,446,054
Page 1 of 1